50 reports

  • A) Global immunology market size
  • IMMUNOLOGY SPECIALIZATION, 2017
  • Immunology
  • World
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

Immunology royalty rates Chapter ## – Leading Immunology deals and dealmakers ##. ##.

  • Health Services
  • Immunology
  • World
  • IMMUNOLOGY THERAPEUTICS MARKET, GLOBAL, PIPELINE FOR IMMUNOLOGY BY STAGE OF
  • IMMUNOLOGY THERAPEUTICS MARKET, GLOBAL, PIPELINE FOR KEY IMMUNOLOGY
  • Immunology
  • World
  • Market Size
  • Johnson & Johnson
  • Novartis AG
  • 3.4.4 Immunology
  • 4.2.4 Immunology
  • Immunology
  • Pharmaceutical
  • Therapy
  • Europe
  • Market Size
  • Proportion of Corneal Graft Rejection to Immunology Clinical Trials, G7 Countries (%), 2015*
  • Proportion of Corneal Graft Rejection to Immunology Clinical Trials, E7 Countries (%), 2015*
  • Clinical Trial
  • Immunology
  • World
  • Product Initiative
  • Oxford BioMedica plc
  • SYNTHETIC PEPTIDES TO AGONIZE FPR1/2 FOR IMMUNOLOGY AND INFECTIOUS DISEASE - DRUG PROFILE
  • SYNTHETIC PEPTIDES TO ANTAGONIZE FPR1/2 FOR IMMUNOLOGY AND INFECTIOUS DISEASE - DRUG PROFILE
  • Immunology
  • Pathology
  • Therapy
  • World
  • Product Initiative
  • 5.5 PHARMACEUTICALS & HEALTHCARE, GLOBAL, IMMUNOLOGY DEALS, AUGUST 2017
  • Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), March 2017 -
  • Immunology
  • World
  • Company
  • Deals & Alliance
  • Dermira, Inc.
  • 7.4 PHARMACEUTICALS & HEALTHCARE, GLOBAL, IMMUNOLOGY DEALS, Q4 2016
  • Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal
  • Endocrine Disease
  • Immunology
  • World
  • Deals & Alliance
  • AstraZeneca PLC
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF FOOD ALLERGY TO IMMUNOLOGY CLINICAL TRIALS
  • Proportion of Food Allergy to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Clinical Trial
  • Drug Discovery And Development
  • Immunology
  • World
  • Product Initiative
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF BONE MARROW TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF BONE MARROW TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS
  • Drug Discovery And Development
  • Immunology
  • Pharmaceutical
  • United States
  • World
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF HEMATOPOIETIC STEM CELL TRANSPLANTATION TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF HEMATOPOIETIC STEM CELL TRANSPLANTATION TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • Biological Therapy
  • Blood Disease
  • Immunology
  • World
  • Product Initiative
  • PROPORTION OF CUTANEOUS LUPUS ERYTHEMATOSUS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF CUTANEOUS LUPUS ERYTHEMATOSUS TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • Clinical Trial
  • Immunology
  • Musculoskeletal Disorder
  • World
  • Product Initiative
  • PROPORTION OF CHURG-STRAUSS SYNDROME TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • PROPORTION OF CHURG-STRAUSS SYNDROME TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • Hospital
  • Immunology
  • Monoclonal Antibody
  • World
  • Product Initiative
  • PROPORTION OF CEDAR POLLEN ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF CEDAR POLLEN ALLERGY TO IMMUNOLOGY CLINICAL TRIALS
  • Allergy Drug
  • Immunology
  • Japan
  • World
  • Product Initiative
  • PROPORTION OF HEREDITARY ANGIOEDEMA (HAE) (C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY) TO IMMUNOLOGY CLINICAL TRIALS, E7
  • PROPORTION OF HEREDITARY ANGIOEDEMA (HAE) (C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY) TO IMMUNOLOGY CLINICAL TRIALS, E7
  • Clinical Trial
  • Immunology
  • World
  • Product Initiative
  • Shire plc
  • PROPORTION OF DRUG HYPERSENSITIVITY REACTIONS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF DRUG HYPERSENSITIVITY REACTIONS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • Immunology
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF CHRONIC INFLAMMATION TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF CHRONIC INFLAMMATION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • Clinical Trial
  • Immunology
  • World
  • Product Initiative
  • Merck & Co., Inc.
  • PROPORTION OF CAT ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF CAT ALLERGY TO IMMUNOLOGY CLINICAL TRIALS
  • Clinical Trial
  • Immunology
  • World
  • Product Initiative
  • Circassia Pharmaceuticals plc
  • PROPORTION OF BIRCH POLLEN ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF BIRCH POLLEN ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • Allergy Drug
  • Immunology
  • World
  • Product Initiative
  • Anergis SA
  • PROPORTION OF CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS (CCLE) / DISCOID LUPUS ERYTHEMATOSUS (DLE) TO IMMUNOLOGY CLINICAL
  • PROPORTION OF CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS (CCLE) / DISCOID LUPUS ERYTHEMATOSUS (DLE) TO IMMUNOLOGY CLINICAL
  • Dermatological Condition
  • Immunology
  • World
  • Product Initiative
  • Celgene Corporation
  • PROPORTION OF ANGIOEDEMA TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • Clinical Trials by E7 Countries: Proportion of Angioedema to Immunology Clinical Trials
  • Allergy Drug
  • Immunology
  • World
  • Product Initiative
  • Shire plc
  • PROPORTION OF ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS (ANCA VASCULITIS) TO IMMUNOLOGY CLINICAL TRIALS, E7
  • Clinical Trials by E7 Countries: Proportion of Anti-Neutrophil Cytoplasmic Antibody- Associated Vasculitis (ANCA Vasculitis) to Immunology Clinical Trials
  • Autoimmune Disease
  • Immunology
  • Monoclonal Antibody
  • World
  • Product Initiative
  • PROPORTION OF HEART TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF HEART TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • Heart Transplant
  • Immunology
  • World
  • Product Initiative
  • Novartis AG
  • UCB SA, DEALS BY THERAPY AREA, 2011 TO YTD 2017
  • Deal in Brief

Leveraging UCB' s scientific expertise in immunology, we will now take the program forward and explore it further in immunology indications where there are severe unmet needs. "

  • Autoimmune Disease
  • Immunology
  • United States
  • Company
  • UCB S.A.
  • PROPORTION OF MILK ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF MILK ALLERGY TO IMMUNOLOGY CLINICAL TRIALS
  • Biological Therapy
  • Immunology
  • Milk
  • World
  • Product Initiative
  • Proportion of Stem Cell Transplantation to Immunology Clinical Trials, E7 Countries (%), 2016*
  • Proportion of Stem Cell Transplantation to Immunology Clinical Trials, G7 Countries (%), 2016*
  • Blood Supply, Tissue Banking And Transplantation
  • Clinical Trial
  • Immunology
  • World
  • Product Initiative
  • Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials, G7 Countries (%), 2016*
  • Proportion of Systemic Lupus Erythematosus to Immunology Clinical Trials, E7 Countries (%), 2016*
  • Chronic Disease
  • Clinical Trial
  • Immunology
  • Musculoskeletal Disorder
  • GlaxoSmithKline plc
  • Clinical Trials by G7 Countries: Proportion of Bone Marrow Transplant Rejection to Immunology Clinical Trials
  • Clinical Trials by E7 Countries: Proportion of Bone Marrow Transplant Rejection to Immunology Clinical Trials
  • Clinical Trial
  • Immunology
  • Pharmaceutical
  • World
  • Product Initiative
  • Clinical Trials by E7 Countries: Proportion of Lupus Erythematosus to Immunology Clinical Trials
  • Proportion of Lupus Erythematosus to Immunology Clinical Trials, G7 Countries (%), 2016*
  • Clinical Trial
  • Drug Discovery And Development
  • Immunology
  • World
  • GlaxoSmithKline plc
  • Proportion of Lung Transplant Rejection to Immunology Clinical Trials, G7 Countries (%), 2016*
  • Proportion of Lung Transplant Rejection to Immunology Clinical Trials, E7 Countries (%), 2016*
  • Immunology
  • Lung Transplant
  • World
  • Product Initiative
  • Novartis AG